Henry K. Litt
Fellows MD Fellow, Hematology/Oncology, University of Pennsylvania LinkedIn of Henry K. Litt
Henry K. Litt, MD is an Innovation Fellow at the Penn Center for Cancer Care Innovation (PC3I) and a Hematology/Oncology Fellow at the University of Pennsylvania. He is interested in leveraging digital tools and artificial intelligence to improve care delivery and decision-making for patients with cancer.
Dr. Litt received both his BA in biology and MD from the University of Chicago. He then completed his internal medicine residency at the University of California San Francisco, before beginning his hematology/oncology fellowship at the University of Pennsylvania.
Henry’s Publications
FDA-authorized oncology artificial intelligence and machine learning devices and their clinical evidence: A cross-sectional analysis
April 21, 2026 | Journal of Cancer Policy
Outcomes of enfortumab vedotin plus pembrolizumab in patients with advanced urothelial cancer and severe renal dysfunction
November 14, 2025 | Urologic Oncology
Quality and Accessibility of Liquid Biopsy Information
May 7, 2024 | JAMA Network Open